Anonymous ID: be4788 Aug. 25, 2020, 2:36 p.m. No.10416952   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun   >>7140 >>7305 >>7419

Avantor, Inc sold by New Mountain Investments: $498.88m-August 21

 

Secondary offering-8-K filing

On August 19, 2020, Avantor, Inc. (the "Company") entered into an Underwriting Agreement (the "Underwriting Agreement"), by and among the Company, the selling stockholders named therein (collectively, the "Selling Stockholders"), and Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC, as underwriters named therein (the "Underwriters"), relating to an underwritten offering of 55,555,555 shares (the "Offered Shares") of the Company's common stock, par value $0.01 per share ("Common Stock"), pursuant to the Company's Registration Statement on Form S-3 (File No. 333-248127), filed on August 19, 2020. The Selling Stockholders also granted the Underwriters a 30-day option to purchase up to 8,333,333 additional shares of Common Stock (the "Option Shares" and, together with the Offered Shares, the "Shares"), which was exercised in full. Pursuant to the Underwriting Agreement, the Selling Stockholders sold the shares for gross proceeds of approximately $1,246 million. The Company did not receive any proceeds from the offering. The offering of the Shares was completed on August 21, 2020.

https://www.marketscreener.com/quote/stock/AVANTOR-INC-58388950/news/AVANTOR-INC-Entry-into-a-Material-Definitive-Agreement-Financial-Statements-and-Exhibits-form-31157647/

 

Avantor, Inc. is a global provider of mission critical products and services. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables includes chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation includes filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Number of employees : 12 000 people.

https://www.marketscreener.com/quote/stock/AVANTOR-INC-58388950/company/

New Mountain Capital (โ€œNew Mountainโ€) is an alternative investment manager with private equity, credit, public equity and net lease strategies. New Mountainโ€™s aggregate assets under management total more than $28 billion across all investment strategies.[1] Since inception, New Mountain has raised over $17 billion of committed capital across five private equity funds and is currently raising its sixth fund New Mountain Capital is based in New York City and was founded in 1999 by Steven B. Klinsky. Prior to founding New Mountain Capital, Klinsky was a general partner of private equity firm Forstmann Little and Co., which he joined in 1984. Prior to that, Klinsky was a co-founder of the leveraged buyout group at Goldman Sachs (1981-1984), where he helped execute over $3 billion of transactions.

https://en.wikipedia.org/wiki/New_Mountain_Capital

https://www.finviz.com/insidertrading.ashx?oc=1515175&tc=7&b=2